Literature DB >> 32797723

Global cardiovascular disease prevention and management: A collaboration of key organizations, groups, and investigators in low- and middle-income countries.

Michael H Olsen1,2,3, Dinesh Neupane1,4, Laura K Cobb5, Thomas R Frieden5, Bethany Hall6,7, Daniel T Lackland8,9, Andrew E Moran5, Qaiser Mukhtar6, Michael Weber8,10.   

Abstract

Entities:  

Keywords:  LMICs; hypertension; mentorship; prevention; trans fatty acids

Mesh：

Year:  2020        PMID： 32797723      PMCID： PMC8029856          DOI： 10.1111/jch.13939

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  9 in total

Review 1.  A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.

Authors:  Michael H Olsen; Sonia Y Angell; Samira Asma; Pierre Boutouyrie; Dylan Burger; Julio A Chirinos; Albertino Damasceno; Christian Delles; Anne-Paule Gimenez-Roqueplo; Dagmara Hering; Patricio López-Jaramillo; Fernando Martinez; Vlado Perkovic; Ernst R Rietzschel; Giuseppe Schillaci; Aletta E Schutte; Angelo Scuteri; James E Sharman; Kristian Wachtell; Ji Guang Wang
Journal:  Lancet       Date:  2016-09-23       Impact factor: 79.321

2.  Clarity in validation protocols for central blood pressure devices.

Authors:  James E Sharman; Jonathan P Mynard; Matthew K Armstrong; Dean S Picone; Martin G Schultz
Journal:  J Hypertens       Date:  2020-05       Impact factor: 4.844

3.  May Measurement Month 2017: an analysis of blood pressure screening results worldwide.

Authors:  Thomas Beaney; Aletta E Schutte; Maciej Tomaszewski; Cono Ariti; Louise M Burrell; Rafael R Castillo; Fadi J Charchar; Albertino Damasceno; Ruan Kruger; Daniel T Lackland; Peter M Nilsson; Dorairaj Prabhakaran; Agustin J Ramirez; Markus P Schlaich; Jiguang Wang; Michael A Weber; Neil R Poulter
Journal:  Lancet Glob Health       Date:  2018-05-16       Impact factor: 26.763

4.  Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial.

Authors:  Dinesh Neupane; Craig S McLachlan; Shiva Raj Mishra; Michael Hecht Olsen; Henry B Perry; Arjun Karki; Per Kallestrup
Journal:  Lancet Glob Health       Date:  2018-01       Impact factor: 26.763

5.  The Accuracy in Measurement of Blood Pressure (AIM-BP) collaborative: Background and rationale.

Authors:  Raj Padwal; Norm R C Campbell; Michael A Weber; Daniel Lackland; Daichi Shimbo; Xin-Hua Zhang; Aletta E Schutte; Michael Rakotz; Gregory Wozniak; Raymond Townsend; Richard McManus; Kei Asayama; Dean Picone; Jordy Cohen; Tammy Brady; Michael Hecht-Olsen; Christian Delles; Bruce Alpert; Richard Dart; Donald J DiPette; James E Sharman
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-19       Impact factor: 3.738

6.  May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.

Authors:  Thomas Beaney; Louise M Burrell; Rafael R Castillo; Fadi J Charchar; Suzie Cro; Albertino Damasceno; Ruan Kruger; Peter M Nilsson; Dorairaj Prabhakaran; Agustin J Ramirez; Markus P Schlaich; Aletta E Schutte; Maciej Tomaszewski; Rhian Touyz; Ji-Guang Wang; Michael A Weber; Neil R Poulter
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

7.  Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group.

Authors:  Raj Padwal; Norm R C Campbell; Aletta E Schutte; Michael Hecht Olsen; Christian Delles; Anthony Etyang; J Kennedy Cruickshank; George Stergiou; Michael K Rakotz; Gregory Wozniak; Marc G Jaffe; Ivor Benjamin; Gianfranco Parati; James E Sharman
Journal:  J Hypertens       Date:  2019-09       Impact factor: 4.844

8.  Global cardiovascular disease prevention and management: A collaboration of key organizations, groups, and investigators in low- and middle-income countries.

Authors:  Michael H Olsen; Dinesh Neupane; Laura K Cobb; Thomas R Frieden; Bethany Hall; Daniel T Lackland; Andrew E Moran; Qaiser Mukhtar; Michael Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-14       Impact factor: 3.738

9.  Scaling up effective treatment of hypertension-A pathfinder for universal health coverage.

Authors:  Thomas R Frieden; Cherian V Varghese; Sandeep P Kishore; Norman R C Campbell; Andrew E Moran; Raj Padwal; Marc G Jaffe
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-23       Impact factor: 3.738
  9 in total
  3 in total

1.  Global cardiovascular disease prevention and management: A collaboration of key organizations, groups, and investigators in low- and middle-income countries.

Authors:  Michael H Olsen; Dinesh Neupane; Laura K Cobb; Thomas R Frieden; Bethany Hall; Daniel T Lackland; Andrew E Moran; Qaiser Mukhtar; Michael Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-14       Impact factor: 3.738

2.  Building research capacity within cardiovascular disease prevention and management in low- and middle-income countries: A collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League.

Authors:  Dinesh Neupane; Laura K Cobb; Bethany Hall; Daniel T Lackland; Andrew E Moran; Qaiser Mukhtar; Michael A Weber; Michael Hecht Olsen
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-31       Impact factor: 3.738

3.  Emerging Authors Program for Global Cardiovascular Disease Research-A collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League.

Authors:  Dinesh Neupane; Bethany Hall; Qaiser Mukhtar; Christian Delles; James E Sharman; Laura K Cobb; Daniel T Lackland; Andrew E Moran; Michael A Weber; Michael Hecht Olsen
Journal:  J Hum Hypertens       Date:  2022-03-23       Impact factor: 2.877
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.